Stocks making the biggest moves midday: Robinhood, Nvidia, Intel and more

Here are the companies making waves during midday trade: Crypto stocks — As bitcoin slid below $50,000 for the first time since February, several related stocks were affected. For instance, Robinhood saw a dip of over 10%, and MicroStrategy fell by over 8%. Additionally, companies like Coinbase and Marathon Digital both declined about 5%. Kellanova… [Read More]

Stocks making the biggest moves premarket: Nvidia, Apple, Kellanova and more

Ahead of the bell, here are the companies grabbing headlines today. Semiconductor giants – Nvidia saw its stocks dive almost 12.5% during premarket trading as the artificial intelligence sector downturn affects prominent semiconductor stocks.   Broadcom decreased around 9%, and both Super Micro Computer and Arm Holdings slipped more than 12%. Apple – The tech titan’s… [Read More]

PRISM Oil and Gas Index Earnings: Gran Tierra Energy (GTE) Reports Q2 Results

This week the PRISM Oil and Gas company Gran Tierra Energy (GTE), announced Q2 EPS of $1.16 compared to a year ago of ($0.33) and achieved 2Q net income of $36M while exiting the quarter with $115M in cash. The company reiterated full-year production guidance, buoyed by positive testing of two new exploration wells. Additionally… [Read More]

Nasdaq 100 Enters Correction Territory Amid AI Stock Sell-Off

Amazon (AMZN) leads stocks lower as traders turn skittish on AI bets. The prospect of rate cuts should boost demand for riskier stocks. The violent rotation from Big Tech plunged the Nasdaq 100 Index into correction territory, wiping out more than $2 trillion in value in just over three weeks, as traders unwound bets that… [Read More]

OS Therapies (OSTX) Announces Formation of Patient Advocacy Advisory Board

Biopharmaceutical company, OS Therapies, Inc. (OSTX) has announced the formation of a Patient Advocacy Advisory Board (PAAB) for its osteosarcoma program. Osteosarcoma is a solid tumor of the bone that predominantly occurs in children and young adults. It is an extremely challenging and often aggressive cancer that has particular treatment challenges due to its location,… [Read More]

META Does ‘Betta’ on Q2 Earnings, Cautions on Capex “Significantly Higher” in 2025

Meta Platforms Inc. (META) announced Q2 financials as revenue surpassed expectations by 2%, while EPS was 9% higher than anticipated. The company also guided Q3 revenue at the midpoint, which is 2% above Street expectations, despite facing more challenging comparisons and foreign exchange impacts. Key takeaways highlighted strong advertising demand across various sectors, with expectations… [Read More]

Are Investors Non-Believers in Moleculin (MBRX) MIRACLE Phase 3 Trail Plans? Stock Down Over 20% on Report

Moleculin Biotech, Inc. (MBRX), a clinical-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced a positive discussion and outcome in its End of Phase 1B/2 (EOP1B/2) meeting with the US Food and Drug Administration (FDA). This outcome supports the advancement of Annamycin in combination with Cytarabine to… [Read More]

Top Takeaways from the Bitcoin 2024 Conference in Nashville

The historic Bitcoin 2024 Conference wrapped up this past weekend in Nashville, TN with organizers announcing from the stage a record-setting crowd of more than 25,000 attendees; marking a significant boost from the roughly 800 participants at the first such conference in 2019 sponsored by Bitcoin Magazine according to Founder and CEO, David Bailey. [Read More]

The Next AI Play: PRISM MarketView Launches AI Infrastructure and Datacenter Index

PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AI Infrastructure and Datacenter Index in response to significant global growth and interest in AI technology. The new PRISM index tracks emerging companies supplying AI-related infrastructure and the datacenters that store this technology. The global AI market… [Read More]